Rockefeller Capital Management’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-24,701
| Closed | -$48K | – | 1807 |
|
|
2023
Q1 | $48K | Hold |
24,701
| – | – | ﹤0.01% | 1927 |
|
|
2022
Q4 | $94K | Sell |
24,701
-270
| -1% | -$1.03K | ﹤0.01% | 2055 |
|
|
2022
Q3 | $120K | Sell |
24,971
-89
| -0.4% | -$428 | ﹤0.01% | 1887 |
|
|
2022
Q2 | $198K | Buy |
25,060
+89
| +0.4% | +$703 | ﹤0.01% | 1637 |
|
|
2022
Q1 | $365K | Hold |
24,971
| – | – | ﹤0.01% | 1444 |
|
|
2021
Q4 | $503K | Hold |
24,971
| – | – | ﹤0.01% | 1311 |
|
|
2021
Q3 | $677K | Hold |
24,971
| – | – | ﹤0.01% | 1151 |
|
|
2021
Q2 | $607K | Sell |
24,971
-54,426
| -69% | -$1.32M | ﹤0.01% | 1112 |
|
|
2021
Q1 | $1.94M | Hold |
79,397
| – | – | 0.01% | 585 |
|
|
2020
Q4 | $2.54M | Buy |
+79,397
| New | +$2.54M | 0.02% | 459 |
|